Efficacy and tolerability of capecitabine with weekly paclitaxel for patients with metastatic breast cancer: a phase II report of the SAKK.

Ute Gick; Christoph Rochlitz; Walter Mingrone; Bernhard Pestalozzi; Daniel Rauch; Pierluigi Ballabeni; Doris Lanz; Viviane Hess; Stefan Aebi

doi:10.1159/000100449

Efficacy and tolerability of capecitabine with weekly paclitaxel for patients with metastatic breast cancer: a phase II report of the SAKK.

Identifier:nobleid.org/w1/20260515/2BCA3FEB

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/2BCA3FEB.svg?ark=w1%2F20260515%2F2BCA3FEB)](https://nobleid.org/work/w1/20260515/2BCA3FEB)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Efficacy and tolerability of capecitabine with weekly paclitaxel for patients with metastatic breast cancer: a phase II report of the SAKK.

Identifier:nobleid.org/w1/20260515/2BCA3FEB

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/2BCA3FEB.svg?ark=w1%2F20260515%2F2BCA3FEB)](https://nobleid.org/work/w1/20260515/2BCA3FEB)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work